Posttransplant cyclophosphamide versus antithymocyte globulin in patients with cardiovascular comorbidity undergoing allogeneic hematopoietic cell transplantation for acute myeloid leukaemia in first complete remission from unrelated donors: a retrospective matched-pair analysis from the ALWP of the EBMT

Jan Vydra, Allain-Thibeault Ferhat, Nicolaus Kröger, Tobias Gedde-Dahl, Matthias Eder, Thomas Schroeder, Urpu Salmenniemi, Régis Peffault de Latour, Jakob Passweg, Ibrahim Yakoub-Agha, Alessandro Rambaldi, Robert Zeiser, Matthias Stelljes, Kristina Carlson, Cristina Castilla-Llorente, Alexandros Spyridonidis, Bipin Savani, Fabio Ciceri, Mohamad Mohty

Open source

DOI
10.1038/s41409-025-02766-0
Published
2025-12-03
Container
Bone Marrow Transplantation
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41409-025-02766-0,
  title = {Posttransplant cyclophosphamide versus antithymocyte globulin in patients with cardiovascular comorbidity undergoing allogeneic hematopoietic cell transplantation for acute myeloid leukaemia in first complete remission from unrelated donors: a retrospective matched-pair analysis from the ALWP of the EBMT},
  author = {Jan Vydra and Allain-Thibeault Ferhat and Nicolaus Kröger and Tobias Gedde-Dahl and Matthias Eder and Thomas Schroeder and Urpu Salmenniemi and Régis Peffault de Latour and Jakob Passweg and Ibrahim Yakoub-Agha and Alessandro Rambaldi and Robert Zeiser and Matthias Stelljes and Kristina Carlson and Cristina Castilla-Llorente and Alexandros Spyridonidis and Bipin Savani and Fabio Ciceri and Mohamad Mohty},
  year = {2025},
  journal = {Bone Marrow Transplantation},
  doi = {10.1038/s41409-025-02766-0},
  url = {https://doi.org/10.1038/s41409-025-02766-0}
}

RIS

TY  - JOUR
TI  - Posttransplant cyclophosphamide versus antithymocyte globulin in patients with cardiovascular comorbidity undergoing allogeneic hematopoietic cell transplantation for acute myeloid leukaemia in first complete remission from unrelated donors: a retrospective matched-pair analysis from the ALWP of the EBMT
AU  - Jan Vydra
AU  - Allain-Thibeault Ferhat
AU  - Nicolaus Kröger
AU  - Tobias Gedde-Dahl
AU  - Matthias Eder
AU  - Thomas Schroeder
AU  - Urpu Salmenniemi
AU  - Régis Peffault de Latour
AU  - Jakob Passweg
AU  - Ibrahim Yakoub-Agha
AU  - Alessandro Rambaldi
AU  - Robert Zeiser
AU  - Matthias Stelljes
AU  - Kristina Carlson
AU  - Cristina Castilla-Llorente
AU  - Alexandros Spyridonidis
AU  - Bipin Savani
AU  - Fabio Ciceri
AU  - Mohamad Mohty
PY  - 2025
JO  - Bone Marrow Transplantation
DO  - 10.1038/s41409-025-02766-0
UR  - https://doi.org/10.1038/s41409-025-02766-0
ER  - 

APA

Vydra, J., Ferhat, A., Kröger, N., Gedde-Dahl, T., Eder, M., Schroeder, T., Salmenniemi, U., Latour, R. P. D., Passweg, J., Yakoub-Agha, I., Rambaldi, A., Zeiser, R., Stelljes, M., Carlson, K., Castilla-Llorente, C., Spyridonidis, A., Savani, B., Ciceri, F., & Mohty, M. (2025). Posttransplant cyclophosphamide versus antithymocyte globulin in patients with cardiovascular comorbidity undergoing allogeneic hematopoietic cell transplantation for acute myeloid leukaemia in first complete remission from unrelated donors: a retrospective matched-pair analysis from the ALWP of the EBMT. Bone Marrow Transplantation. https://doi.org/10.1038/s41409-025-02766-0

Source records